Inovio Pharmaceuticals, Inc., an innovative biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases, reported financial results for the third quarter ended September 30, 2019.
November 12, 2019
· 13 min read